SEC Form 4 · accession 0001615219-15-000079
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Perez
Director
Period of report
Nov 11, 2015
Accepted (ET)
Nov 20, 2015 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.05 | Nov 11, 2015 | A | 20,000 | A | — | Nov 11, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option will vest in 36 successive equal monthly installments measured from September 2, 2015.